For research use only. Not for therapeutic Use.
Hoquizil (Cat.No:I028865) is a psychoactive compound belonging to the class of quinolinone derivatives. It acts as a dopamine receptor antagonist and has been studied for its potential antipsychotic properties. Hoquizil exhibits neuroprotective effects and has shown promise in the treatment of various neurological disorders, including schizophrenia and Alzheimer’s disease.
| Catalog Number | I028865 |
| CAS Number | 21560-59-8 |
| Synonyms | Hoquizil |
| Molecular Formula | C19H26N4O5 |
| Purity | 98% |
| Solubility | To be determined |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 1-Piperazinecarboxylic acid, 4-(6,7-dimethoxy-4-quinazolinyl)-, 2-hydroxy-1-methylpropyl ester |
| InChI | InChI=1S/C19H26N4O5/c1-19(2,25)11-28-18(24)23-7-5-22(6-8-23)17-13-9-15(26-3)16(27-4)10-14(13)20-12-21-17/h9-10,12,25H,5-8,11H2,1-4H3 |
| InChIKey | YRTMGQYDLITGNA-UHFFFAOYSA-N |
| SMILES | COc1cc2ncnc(N3CCN(CC3)C(=O)OCC(C)(C)O)c2cc1OC |
| Reference | 1. Scillitani B, Thomas J, Brewer TF, Lyons H, Steen SN. Hoquizil–a new oral bronchodilator. A double-blind, randomized, coded clinical study using body plethysmography. Acta Anaesthesiol Scand Suppl. 1969;37:299-302. doi: 10.1111/j.1399-6576.1970.tb00930.x. PMID: 4912116. |
